Coherus Oncology
Commercializes LOQTORZI while advancing mid-stage immuno-oncology antibodies.
$1.39
After-hours close−0.02 (−1.42%)
At close$1.41(−3.42%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 46.32%71.57M sharesInsiders 0.90%1.39M sharesOther 52.78%81.54M shares
Shares outstanding 154.50M · Float 134.81M · 87.3% free float
Institutions13F, as of Jun 30, 2026
152 holders · 71.57M shares · 13 new positions · 75 increased · 42 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable Trust | 13.05M | 8.45% | +759.8K | Aug 7, 2026 |
| BlackRock, Inc. | 12.00M | 7.77% | +1.64M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 5.95M | 3.85% | +496.7K | Aug 13, 2026 |
| Geode Capital Management, LLC | 3.69M | 2.39% | +564.0K | Aug 12, 2026 |
| Samsara Biocapital, LLC | 3.43M | 2.22% | 0 | Aug 14, 2026 |
| Kohlberg Kravis Roberts & Co. L.P. | 3.04M | 1.97% | 0 | Aug 14, 2026 |
| State Street Corp | 2.38M | 1.54% | +56.4K | Aug 7, 2026 |
| Two Sigma Investments, LP | 2.26M | 1.46% | −42.6K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Rubric Capital Management LPincl. David Rosen | 9.03% | 10.40M | 13G | Nov 13, 2024 ↗ |
| Timothy G. Youngquist 2020 Irrevocable Trust | 8.30% | 12.75M | 13G | May 15, 2026 ↗ |
| BlackRock, Inc. | 5.80% | 8.93M | 13G | Jul 27, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Dennis M. Lanfear | director, officer: President & CEO | 1.05M | 0.68% | Jan 26, 2026 |
| Bryan J. McMichael | officer: Chief Financial Officer | 133.7K | 0.09% | Jan 26, 2026 |
| Rita A. Karachun | director | 30.0K | 0.02% | Jun 9, 2026 |
| Lee Nisley Newcomer | director | 30.0K | 0.02% | Jun 9, 2026 |
| Charles W. Newton | director | 30.0K | 0.02% | Jun 9, 2026 |
| Jill O'Donnell-Tormey | director | 30.0K | 0.02% | Jun 9, 2026 |
| Michael Lee Ryan | director | 30.0K | 0.02% | Jun 9, 2026 |
| Ali J. Satvat | director | 30.0K | 0.02% | Jun 9, 2026 |
| Mats Wahlstrom | director | 30.0K | 0.02% | Jun 9, 2026 |
6 ten-percent owners hold 21.34M shares by Form 4, outside the officers-and-directors figure above · 18 people have not refiled in the last 18 months (2.89M shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.